Show simple item record

AuthorAl-Awar A.
AuthorAlm?si N.
AuthorSzab? R.
AuthorTakacs I.
AuthorMurlasits Z.
AuthorSz?cs G.
AuthorT?r?k S.
AuthorP?sa A.
AuthorVarga C.
AuthorKupai K.
Available date2020-02-24T08:57:14Z
Publication Date2018
Publication NameInternational Journal of Molecular Sciences
ResourceScopus
ISSN16616596
URIhttp://dx.doi.org/10.3390/ijms19103226
URIhttp://hdl.handle.net/10576/13012
AbstractDipeptidyl peptidase-4 (DPP-4) inhibitors are a class of oral anti-diabetic drugs, implicated in pleiotropic secondary cardioprotective effects. The aim of the study was to unveil the unknown and possible cardioprotective targets that can be exerted by sitagliptin (Sitg) against ischemia-reperfusion (I/R) injury. Male wistar rats received 2 weeks? Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. NOS inhibitor (L-NAME) and TRPV-1 inhibitor (Capsazepine) were utilized to confirm the implication of both signaling mechanisms in DPP-4 inhibition-induced at the level of IS. Findings show that Sitg (50 mg) resulted in significant decrease in IS and DPP-4 activity, and significant increase in GLP-1, NOS activity, e-NOS expression, TRPV-1 level and TRPC-1 expression, compared to controls. Results of CGRP are in line with TRPV-1, as a downstream regulatory effect. NOS system and transient receptor potential (TRP) channels can contribute to DPP-4 inhibition-mediated cardioprotection against I/R injury using Sitagliptin.
SponsorThis research was funded by GINOP grant number 2.3.2-15-2016-00035.
Languageen
PublisherMDPI AG
SubjectCalcitonin gene related peptide
SubjectDipeptidyl-peptidase-4
SubjectDPP-4 inhibitors
SubjectEndothelial nitric oxide synthase
SubjectInfarct size
SubjectIschemia-reperfusion injury
SubjectNOS activity
SubjectTransient receptor potential channels
TitleNovel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model
TypeArticle
Issue Number10
Volume Number19


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record